This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
This page refreshes automatically every 30 mins. Press F5 to update manually
For a more detailed explanation of Upgrades/Downgrades see Link
Key: (?) = Upgraded, (?) = Downgraded, (-) = Maintained
| Stock | Broker Update |
| Aberdeen Asset Management | RBC ups TP to 550p from 480p, outperform |
| AVEVA | JP Morgan ups TP to 2450p from 2430p, neutral |
| AVEVA | Liberum cuts TP to 2250p from 2350p, Hold |
| Barclays | Jefferies cuts TP to 364p from 367p, Buy |
| Burberry | Exane BNP Paribas cuts TP to 1640p from 1670p, neutral |
| Capita | Barclays ups TP to 1050p from 885p, Equalweight |
| Capita | JP Morgan ups TP to 1240p from 1230p, overweight |
| Capita | Credit Suisse drops from focus list; keeps outperform rating |
| Caracal Energy | Canaccord Genuity cuts TP to 820p from 920p, Buy |
| European insurance | Nomura cuts sector view to neutral from bullish |
| First Quantum Minerals | Morgan Stanley ups TP to 1230p from 1200p, overweight |
| Greencore Group | Oriel Securities ups TP to 210p from 160p, Buy |
| International Consolidated Airlines | HSBC ups TP to 430p from 420p, overweight |
| Keller | Jefferies ups TP to 1360p from 1350p, Buy |
| MAN Group | RBC ups TP to 90p from 80p, underperform |
| Petrofac | JP Morgan cuts TP to 1746p from 2215p, overweight |
| Petrofac | Citigroup cuts TP to 1525p from 1600p, Buy |
| Petrofac | SocGen cuts TP to 1560p from 1580p, Buy |
| Petrofac | Credit Suisse cuts TP to 1535p from 1800p, outperform |
| Petrofac | HSBC cuts TP to 1225p from 1300p, neutral |
| Regenersis | Panmure ups TP to 402p from 302p, Buy |
| Serco | HSBC cuts TP to 520p from 635p, overweight |
| StatPro Group | Panmure initiates with Buy; TP 124p |
| WS atkins | Jefferies ups TP to 1300p from 1075p, Hold |
| Source: Reuters News, AlphaTerminal, Dow Jones Newswires | |
Source: Bloomberg, Reuters News, AlphaTerminal, Dow Jones Newswires
T111his research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research